Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment

NCT01495208 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Fibrovascular Pigment Epithelial Detachment

Interventions

DRUG: Aflibercept

Sponsor

Vitreous -Retina- Macula Consultants of New York

Collaborators

[object Object]